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Abstract
Background: Modeling the cell-division cycle has been practiced for many years. As time has progressed, this
work has gone from understanding the basic principles to addressing distinct biological problems, e.g., the nature
of the restriction point, how checkpoints operate, the nonlinear dynamics of the cell cycle, the effect of
localization, etc. Most models consist of coupled ordinary differential equations developed by the researchers,
restricted to deal with the interactions of a limited number of molecules. In the future, cell-cycle modeling–and
indeed all modeling of complex biologic processes–will increase in scope and detail.
Results: A framework for modeling complex cell-biologic processes is proposed here. The framework is based on
two constructs: one describing the entire lifecycle of a molecule and the second describing the basic cellular
machinery. Use of these constructs allows complex models to be built in a straightforward manner that fosters
rigor and completeness. To demonstrate the framework, an example model of the mammalian cell cycle is
presented that consists of several hundred differential equations of simple mass action kinetics. The model
calculates energy usage, amino acid and nucleotide usage, membrane transport, RNA synthesis and destruction,
and protein synthesis and destruction for 33 proteins to give an in-depth look at the cell cycle.
Conclusions: The framework presented here addresses how to develop increasingly descriptive models of
complex cell-biologic processes. The example model of cellular growth and division constructed with the
framework demonstrates that large structured models can be created with the framework, and these models can
generate non-trivial descriptions of cellular processes. Predictions from the example model include those at both
the molecular level–e.g., Wee1 spontaneously reactivates–and at the system level–e.g., pathways for timing-critical
processes must shut down redundant pathways. A future effort is to automatically estimate parameter values that
are insensitive to changes.
Background
Most researchers keep a serviceable mental model of
how molecules of interest react with each other in var-
ious cellular pathways. Such qualitative models suffice
for many purposes. They can, however, break down
when trying to explain more complex interactions
between molecules, e.g., when a molecule participates in
multiple pathways; when the activity or the appearance
of the molecule is dependent on multiple reactions;
when the timing of reactions is important; when multi-
ple processes interact, etc. For such reasons, quantitative
modeling of complex biologic processes, such as the
eukaryote cell cycle, has been practiced for many
decades. (For a general review of cell-cycle modeling,
see [1-3] and references therein.) These efforts have pro-
duced descriptions of cell-cycle subprocesses (e.g., [4])
and predictions (e.g., [5]; [6] testing of [7]) beyond the
realm of mental models.
As the work reported here involves cell-cycle model-
ing as an example of modeling complex biologic pro-
cesses, a brief summary and discussion of recent
eukaryote cell-cycle work follows. Chen et al. [5,7]
examined the cell-cycle regulation of budding yeast.
Novak and Tyson [8] extended this work to mammalian
cells, proceeding on a generalization by Nurse [9,10]
that molecular cell-cycle controls are similar in all
eukaryotes. Novak and Tyson also used the model to
examine restriction point control. Other efforts have
continued this trend of quantitative models being used
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and extensions: localization [5,11], checkpoints [4,12],
apoptosis [13], multisite phosphorylation [14], cell
growth and size control [15,16], etc. Several efforts also
have looked at the nonlinear dynamics of cell-cycle
regulation [17-20].
In detail most of the models used in these efforts are
different; however, in general they are constructed in a
similar fashion. All consist of coupled ordinary differen-
tial equations (ODEs), typically based on wiring dia-
grams of the molecular pathways of importance to the
cell cycle (e.g., the interaction of cyclins and cyclin-
dependent kinases; for the ultimate molecular interac-
tion map of the mammalian cell cycle, see [21]). The
equations of state are based on specific molecules, and
the solutions are for the concentration of each impor-
tant molecule. Although most state equations are based
on simple mass action kinetics, the rate constants are
often enhanced with combinations of constants or with
other functions (e.g., the Goldbeter-Koshland function
used by [22] and [5] and discussed by [23]), presumably
necessary to achieve appropriate behavior. An exception
is the use of diffusion equations (and approximations
thereof) for membrane transport in the work of Yang
et al. [16]. Rate constants and initial concentrations are
based, where possible, on experimental data; although as
noted by [24], few if any of these values have been mea-
sured directly and they must be estimated, typically by
trial and error. Cell division, when included in a model,
is achieved by reducing the cell size by one half (e.g.,
[18]). Growth of the cell as well as transcription and
translation of the regulatory proteins (not to mention
the proteins that comprise the bulk of the cell) are infre-
quently accounted in these models (for an exception, see
[11]). When growth is accounted, the purpose is to
investigate size control–the idea that the cell must reach
a certain size for some of the cell-cycle regulatory pro-
cesses to occur. Yang et al. [16] used cell volume and
nuclear-membrane surface area to model size control.
Qu et al. [15] based size control on growth-signal trans-
duction being proportional to membrane surface area.
Csikász-Nagy et al. [18] discussed the synthesis rates of
cyclins as a form of size control. Other aspects of cell
growth e.g., energy usage or membrane synthesis, are
not considered in these models. In these efforts, steady-
state (G0) behavior of the models is rarely discussed.
The work presented here follows in the footsteps of
the efforts discussed above. One missing element in
these efforts, and other modeling efforts dealing with
complex biologic processes, is a framework with which
to capture the necessarily increasing scope and detail
that such quantitative models will achieve as they pro-
gress. A framework for modeling the mammalian cell
cycle is proposed here. The proposed framework is
composed of two constructs, which describe (1) a mole-
cule lifecycle and (2) basic cellular machinery–which is
in turn built of molecule-lifecycle constructs. The con-
structs are based on techniques used in System
Dynamics [25]. Although at first glance cumbersome, it
offers a structure that readily allows modification and
extension. A benefit of the framework is that it allows
accounting of all processes that are important to a cell-
biologic system in a straightforward and rigorous man-
ner to the extent currently possible. Another benefit is
that using the framework, a researcher can first concen-
trate on modeling each individual molecule, then on the
interactions of the molecule s ,t h e no nt h ei n t e r a c t i o n s
between the molecules and the functioning of the cell.
As in most previous work, the framework is based on
coupled ODEs. A number of different computational
techniques have been proposed and investigated for
modeling biological pathways, including Stochastic Petri
Nets (e.g., [26]), P Systems (e.g., [27]), Brane Calculus
(e.g. [28]), Rule-Based Modeling (e.g., [29]), combination
approaches (e.g., [30]), etc. For a general discussion see
[31,32]. Each of these techniques has merit, although
none solve the problem of complexity that will be
encountered as models necessarily increase in scope and
detail. Coupled ODEs are used here because they have
been traditionally used, they can deal with large num-
bers of molecules and, with the framework described
here, they can be derived and solved with relative facil-
ity. The implications of using coupled ODEs are dis-
cussed in Additional file 1.
To demonstrate the use of the framework constructs,
a model of the growth and division of a mammalian cell
is presented. The model consists of several hundred
ODEs and parameters, but it tracks molecules from
birth to death, accounts for nuclear compartmentaliza-
tion, and operates respecting the underlying use of
amino acids, nucleotides, ATP, mRNA, rRNA, etc. The
model executes relatively quickly, but requires a stiff
equation solver (Matlab http://www.mathworks.com
function ode15s; similar to that used by [5]) because of
the disparity in the timescales of the reactions. The
model returns interesting, albeit unconfirmed, predic-
tions. The model also demonstrates that the framework
is useful, not the least because the major effort was not
in the creation of the model, but in the calibration.
What likens the work presented here to other mam-
malian cell-cycle modeling efforts are (1) the use of
ODEs to describe the mass action kinetics of chemical
reactions and thereby provide a quantitative basis for
the modeling (see Additional file 1), (2) the use of
researcher-developed state and rate equations, based on
literature sources where possible, and (3) the use of
researcher-estimated parameters (see Additional file 2).
A conscious attempt was made here to use the simplest
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tion, although some processes were simplified to the
extent that more complicated expressions had to be
used, e.g., for proton transport across the mitochondrial
membrane. Some researchers have attempted to use a
standard set of kinetic parameters and parameter esti-
mation techniques (e.g., [4]); in this work, the need to
meet multiple global and local constraints for calibration
at both steady state and cell cycling militated against
this approach. An attempt was made to match concen-
tration values, which partially constrain kinetic rates, to
those reported in the literature.
What differentiates this work from other efforts are
the aspects that involve completeness and comprehen-
siveness that are allowed by the framework. The exam-
ple model describes both steady-state (G0) behavior and
dynamic growth and division of a cell, using the same
set of kinetic parameters. The model describes in a
comprehensive fashion many processes that are indivi-
dually examined in other efforts: nuclear localization
(see also [5,11,16]), membrane transport (see also [16]),
and growth factors (although still “highly stylized,” in
the words of Novak and Tyson [8]). The model
describes in a comprehensive fashion many processes
that are omitted from other efforts: usage of sugars,
ATP, nucleotides, and amino acids, synthesis of RNAs–
mRNA, rRNA, tRNA, and snRNA–and the action of
multiple transcription factors (E2F, B-Myb, NF-Y, and a
generic TF-grow meant to represent c-myc, c-Jun,
Notch, etc.). Further, the production and degradation of
all molecules in the model are tracked (see also [11]).
Details concerning features and operation of the model
are presented in Additional file 3. As a final differentia-
tion, this work is not directed at a specific biological
issue–although some biological predictions are pre-
sented and an investigation of a redundant pathway is
included in Additional file 4–rather, it addresses what
will be necessary to progress the modeling of complex
biologic processes.
Results
Molecule-lifecycle construct
Figure 1 illustrates a construct that describes the life-
cycle of a protein. Constructs such as these can also
apply to other molecules in the cell, e.g., RNA, amino
acids, ATP, etc. In the construct, the rectangles corre-
spond to states, and the circles correspond to the rates
that allow a molecule to go from one state to another.
The cloud at the top of the construct symbolizes the
start of the lifecycle, and proteins enter the lifecycle at
the translation rate (txl_p). Proteins first enter the
unfolded state (p_unfold), then they either decay
(dk_p_unfold) to the trash state (p_trash) or are folded
(fold_p) into proteins in the cytosol (p_cytosol). Once in
the cytosol, this protein either decays (dk_p_cytosol) or
binds another molecule (bind_p) and proceeds to the
bound or active state (p_in_use). From the in-use state,
the protein either decays (dk_p_in_use) or unbinds
(unbind_p). Other details can be readily added to this
construct, e.g., transfer between cellular compartments
or interaction with other molecules. The lifecycle con-
struct is so named because it can account for molecules
continually being created and degraded and used and
reused.
State and rate equations are assigned to the construct
in a straightforward manner as follows. The change in
the number of molecules in a given state is dependent
on the number of molecules entering that state, minus
the number of molecules leaving that state, as described
by the ODE dC/dt = Rin -R out , where C is the concen-
tration of molecules of a given molecule type in a given
state, t is time, dC/dt is the change over time in the
concentration of molecules, Rin is the rate of molecules
entering the state, and Rout is the rate of molecules leav-
ing the state. Rates can apply to chemical reactions or
transition from one compartment in a cell to another.
Rates are typically calculated as the product of a rate
Figure 1 Construct for the lifecycle of a protein.C i r c l e s
represent rate equations; rectangles represent state equations (see
text). The protein is described from translation (txl_p), through
folding (fold_p), through cyclical interaction with other molecules
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cules: R = kC1C2..., where k is the rate constant, C1 is
the concentration of the first reactant, C2 is the concen-
tration of the second reactant, etc. Parameter values that
are unknown and must be fitted to the model are the
rate constants and the initial concentrations of the
states. The construct shown in Figure 1 is a simplifica-
tion; seven states typically represent the lifecycle for a
protein in the example cell-cycle model, and five states
represent the lifecycle of the mRNA for the protein. The
most complex molecule lifecycle construct in the exam-
ple model is for cycA; it includes 10 states and 23 rates
describing interactions of cycA with Cdk2, p27, and
Cdk1, as well as cycA activity in cytosol and in the
nucleus (Additional file 5).
Framework overview–cell growth
Underlying the example mammalian cell-cycle model is
a construct that ties the cell cycle to the rest of the cell
and ensures overall self-consistency: (1) it is used for
calibration purposes (Additional file 2); (2) it calculates
available quantities of cellular nucleotides (NT), amino
acids (AA), RNA, ATP, proteins, and lipids over time;
(3) it calculates the transcription rate and the translation
rate for the entire cell; (4) it is used to determine the
normalized size of the cell (assumed to be related to the
number of proteins), which is used to estimate the con-
centrations of all molecules.
The basic-cellular-machinery model consists of 41
ODEs and 69 rate equations (Additional file 6). Figure 2
shows the framework of the model construct (lipids not
shown). The molecular lifecycles interact through their
rate equations; the thinner lines in Figure 2 indicate the
interactions. For example, the number of tRNA being
bound to amino acids (bind_tRNA) is a function of the
number of amino acids available (AA_in_cytosol), which
ultimately influences then u m b e ro fp r o t e i n sb e i n g
translated (txl_p). In the diagram, the thin lines from
the use of ATP are omitted, but they would extend to
most of the rates.
Figure 2 Base model for keeping track of underlying cell processes. Constructs represent generic molecule types, e.g., proteins, rRNA,
spliceosomes, etc. Thick double lines indicate flows from one state (rectangle) to another controlled by the rate equations (circles); thin
connecting lines indicate inputs to state and rate equations.
Gauthier and Pohl BMC Systems Biology 2011, 5:3
http://www.biomedcentral.com/1752-0509/5/3
Page 4 of 16Framework overview–cell-cycle regulation
The cell-cycle model calculates the quantities of 33 pro-
teins, and their concomitant 33 mRNAs, over time.
T h e s ep r o t e i n sc o n s t i t u t ea na p p r o x i m a t em i n i m u ms e t
necessary to describe the mammalian cell cycle. Table 1
summarizes these proteins and their interactions. Illus-
trations of the lifecycle diagrams of these proteins are
presented in Additional file 5. Many of these “proteins”
are not strictly single molecules, but rather abstractions
of proteins that include representative members of pro-
tein complexes and pathways (Additional file 1). The
example model exclusive of the basic-cellular-machinery
model consists of 387 ODEs and approximately 1100
rate equations (Additional file 6).
Testing
A brief overview of the example cell-cycle model results
are presented here. See Additional file 3 for a more
complete description.
Cell growth
The results start with a cell in steady state, G0 phase.
The cell cycle then consists of doubling the cell’sc o n -
tents, followed by the division of the cell in two. G1 is
the initial growth phase; S phase is when DNA is repli-
cated; G2 is the later growth phase; M is the division
phase. In the results presented here, G1 begins at 2×10
4
seconds (~0.25 days) with the imposition of mitogen
and adhesion factors. Although no steady-state results
are presented, the G0 values are indicated in the early
time values in the plots that follow.
The example model tracks a single cell. Figure 3
s h o w sh o wt h en u m b e ro fp r o t e i n si nt h i sc e l lv a r i e s
over 10 days. Protein number increases starting at 0.25
days and then suffers an abrupt decline at 2 days when
the cell divides; the cycle is then repeated approximately
every 1.3 days. The rate of growth slows near the peak
of the curve, when transcription and translation slow
during M phase. The peaks and troughs of each cycle
are not equal (because the solution step occurs at a dif-
ferent point in the cell-division process for every cycle);
however, the example model cycles within reasonable
bounds for dozens of cell divisions.
Figure 4 shows how the number of nucleotides in
D N Av a r i e so v e r1 0d a y s .Ap ositive slope indicates S
phase; the maxima indicate G2 and M; the abrupt nega-
tive slope indicates cell division. The first DNA replica-
tion is from approximately 1.3 days (the G1/S boundary)
to approximately 1.6 days (the S/G2 boundary).
In the model, cell growth rate is directly related to the
number of active RNA polymerases. Figure 5 shows how
numbers of RNA polymerase (the sum of polymerase
type I, II, and III) vary from state to state as the cell
cycle progresses. During G0 phase, ~3×10
4 RNA
polymerases are present [33], but most are held inactive
by cycC/Cdk8 [34,35]. The substantial excess of RNA
polymerase is necessary for the cell cycle to initiate and
progress at a reasonable rate; without this excess during
G0, approximately a week is needed to build up enough
RNA polymerase before the cell can divide. One predic-
tion of the model (see Predictions below) is that main-
taining this pool of RNA polymerase is a major
determinant as to whether the cell is actually capable of
dividing.
Mitogen causes inactivation of cycC/Cdk8 beginning
at 2×10
4 seconds or ~0.25 days in the example model
(mitogen activates KPC which ubiquitinates cycC/Cdk8),
allowing most RNA polymerase to activate. In the
model, active RNA polymerase continually attach and
detach from DNA, polymerizing mRNA when attached.
RNA polymerase numbers increase during the cell cycle
because some of the new mRNA being generated is for
new RNA polymerase; RNA polymerase transcription is
enhanced by c-myc (represented in the model as part of
a collection of molecules called TF-grow). RNA poly-
merase continues to transcribe mRNA throughout S
phase (see Predictions). During M phase, initially at
1.8 days, APC(Cdc20) acts to release RNA polymerase
from DNA. When initially unbound, these RNA poly-
merases are still active, but they are inactivated as Cdc14
reactivates cycC/Cdk8. Some RNA polymerase remains
bound to DNA through the cell division (see Predictions).
The initial cell cycle after G0 is prolonged by a few
hours while the active RNA polymerase builds the
appropriate amounts of rRNA, tRNA, and DNA poly-
merase. In subsequent cell cycles, large amounts of
these molecules plus activated RNA polymerase are
available sooner, thus allowing for quicker growth and
a shorter cycle time.
Cell-cycle regulation
G0 steady state is maintained primarily by p27. Applica-
tion of mitogen and adhesion factor initiates G1. The
duration of the initial G1 is approximately 24 hours;
subsequent G1 phases last approximately 15 hours; the
initial G1 after G0 is timed by p27, subsequent G1
phases are timed primarily by APC(Cdh1). Mitogen
cause the accumulation of cyclins and KPC. The pre-
sence of both mitogen and adhesion factor are required
for cycA accumulation. The cyclins (cyc) bind with their
appropriate kinases (Cdk); Cdks are for the most part
constitutive. The cyc/Cdk ar eb o u n da n di n h i b i t e db y
p27. cycD/Cdk4or6, whether bound to p27 or free,
releases inhibitor Rb from the E2F transcription factor
(see Predictions), E2F then induces many cell-cycle and
cell-growth proteins.
Three other transcription factors are included in the
example model: B-Myb, NF-Y, and a generic TF-grow,
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PROTEIN LOC G0 UBIQ INDUCER ACTIVATOR INACTIVATOR FUNCTION
1 p27 N high KPC, SCF(Skp2), APC
(Cdc20)
constitutive inhibits cyclins–prevent S
2 Rb N high constitutive,
E2F inhibits
Cdc14* cycD/Cdk4or6,
cycE/Cdk2, cycA/
Cdk2, cycA/Cdk1,
cycB/Cdk1
inhibits E2F
3 cycD N 0 SCF(Skp2), APC(Cdc20)* mitogen,
B-Myb*
Cdk4or6 activates Cdk4or6 kinase; inactivates
APC(Cdh1)
4 Cdk2 N high constitutive,
E2F
cycE, cycA,
Cdc25A
kinase–phosphorylates RC–allows DNA
replication
5 cycE N 0 SCF(Fbw7)–on Cdk2,
SCF(Skp2)–free
E2F Cdk2 p27 activates Cdk2 kinase
6 B-Myb N 0 SCF(Skp2)–free E2F, B-Myb cycA/Cdk2,
cycE/Cdk2*
TF for cycD, Cdk1, Plk1, DNA pol, B-
Myb, TF-grow, others
7 NF-Y N 0 ? constitutive,
E2F
cycA/Cdk2,
cycE/Cdk2*
Cdc14* TF for cycA, cycB, Cdk1, Cdc25C, TF-
grow
8 E2F N 0 SCF(Skp2),
APC(Cdc20)*
constitutive,
E2F,
B-Myb
inhibits**
Rb, cycB/Cdk1,
cycA/Cdk2**, cycA/
Cdk1**, cycD/
Cdk4or6**
TF for cycE, cycA, Rb, Cdk1, Cdk2, E2F,
Cdk25A, DNA pol, others
9 cycA N 0 APC(Cdh1), SCF(Skp2)**,
APC(Cdc20)**
E2F, NF-Y,
mitogen,
adhesion**
Cdk2, Cdc25A,
Cdk1, Cdc25A,
Cdc25B,
Cdc25C
p27 (for cycA/
Cdk2), Wee1 (for
cycA/Cdk1)
activates Cdk2 and Cdk1 kinases
10 SCF CN 0 APC(Cdh1) constitutive Skp2, Btrc,
Fbw7
ubiquitinase (requires subunit)
11 Skp2 N 0 auto (when no Emi1 or
Wee1), APC(Cdh1)
constitutive SCF ubiquitinase subunit for p27, E2F, RC,
TF-grow, B-Myb, free cycE, cycA, cycD,
others
12 Btrc C 0 auto (when no p27,
cycE, E2F, or RC), APC
(Cdh1), APC(Cdc20)
E2F SCF ubiquitinase subunit for Emi1, Cdc25A
(sometimes), Wee1, others
13 Fbw7 N 0 auto (when no cycE,
TF-grow**, or RC**)
E2F SCF ubiquitinase subunit for cycE, TF-grow,
RC**
14 TF-grow
(e.g.,
c-myc,
c-Jun,
Notch)
N 0 SCF(Skp2), SCF(Fbw7)
(not ubiquitinated while
TF-grow is on DNA)*
mitogen,
Skp2, B-Myb
TF for cell growth
15 RC (e.g.,
hORC1,
hCdc6)
N 0 SCF(Fbw7)**, SCF(Skp2),
APC(Cdh1)
E2F cycE/Cdk2,
cycA/Cdk2,
cycD/Cdk4or6
cycA/Cdk1, p27 DNA replication complex
16 DNA poly N 0 E2F, B-Myb,
NF-Y*,
inhibits
itself*
RC DNA polymerase
17 Wee1 C high SCF(Btrc) constituitive Cdc14 cycA/Cdk2**, cycA/
Cdk1**, cycB/
Cdk1**, Plk1
kinase–prevents Cdk1 activation
18 cycB CN 0 APC(Cdc20), APC(Cdh1) E2F, B-Myb,
NF-Y
Cdk1 activate Cdk1 kinase
19 Cdk1 CN high* E2F, B-Myb,
NF-Y,
constitutive
cycA, cycB,
B-Myb,
NF-Y, Plk1,
Cdc25A,
Cdc25B,
Cdc25C
Wee1, Cdc14 kinase–activates APC(Cdc20)
20 Cdc25C CN high constitutive,
NF-Y**
cycB/Cdk1, Plk1,
cycA/Cdk1*
Cdc14 phosphatase–activates cycB/Cdk1
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21 Plk1 C 0 APC(Cdh1) E2F, TF-
grow
cycB/Cdk1,
cycA/Cdk1*
kinase–activates Cdc25C; deactivates
Emi1, Wee1; translocates cycA/Cdk1,
cycB/Cdk1, Cdc25C, and Plk1 to
nucleus
22 Emi1 CN 0 SCF(Btrc), SCF(Skp2)* E2F cycB/Cdk1, cycA/
Cdk1*
inhibits Cdh1, Cdc20
23 APC N high constitutive Cdh1, Cdc20 ubiquitinase (requires subunit)
24 Cdh1 N high auto (when no Skp2,
cycA, cycB, Cdc25A,
Plk1, RC, Cdc20, SCF*,
p27**)
constitutive APC, Cdc14 Emi1, cycA/Cdk2,
cycB/Cdk1, cycD/
Cdk4or6, cycE/Cdk2
ubiquitinase subunit–maintains G0,
G1–ubiq Cdc20, cycA (free), cycB (free),
Cdc25A, RC, Plk1, Skp2, others
25 Cdc20 N 0 APC(Cdh1) constitutive APC, cycB/Cdk1,
cycA/Cdk1*
Emi1, Cdc14 ubiquitinase subunit for Securin, cycB,
cycA
26 Cdc14
(represents
MEN
pathway)
N high constitutive Plk1* Securin phosphatase–ends M–activates p27,
Wee1, Cdh1; deactivates Cdc25A,
Cdc25B, Cdc25C
27 Cdc25A N 0 APC(Cdh1), SCF(Btrc)* constitutive,
E2F, TF-
grow
cycE/Cdk2,
cycA/Cdk2,
cycA/Cdk1*,
cycB/Cdk1*
Cdc14 phosphatase–activates cycE/Cdk2,
cycA/Cdk2, cycA/Cdk1*, cycB/Cdk1*
28 Cdc25B C 0 APC(Cdh1)*, SCF(Btrc)* E2F*, TF-
grow*,
TF-grow**,
cycA/Cdk1*,
cycB/Cdk1*
Cdc14 phosphatase–activates cycA/Cdk1,
cycB/Cdk1*
39 Securin N 0 APC(Cdc20) E2F keeps separase from destroying
chromotin cohesion proteins
30 cycC N high constitutive Cdk8, Cdc14* mitogen* inhibits RNA pol
31 KPC N constitutive mitogen ubiquitinase for p27
32 RNA poly N high constitutive,
TF_grow*
mitogen* cycC/Cdk8, APC
(Cdc20)*
txs
33 eIF-4 C high constitutive mRNA initiates txl
The proteins represent different layers of abstraction (see Additional file 1). LOC = location, N = nucleus, C = cytoplasm, G0 = steady-state concentration,
UBIQ = ubiquitinating molecules, auto = autoubiquitination, INDUCER = molecule effecting transcription, ACTIVATOR = molecule promoting activity,
TF = transcription factor, txs = transcription, txl = translation, ? = unknown, * = assumed, ** = ignored.
Figure 3 Number of proteins in a single cell over 10 days. The cell starts in G0, then cycles through seven divisions.
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phases, decreasing slopes indicate cell division.
Figure 5 Number of RNA polymerase over two cell divisions starting from G0. RNA polymerase proteins are constitutive with
enhancement by growth factors (TF-grow). The blue line indicates RNA polymerase that is held inactive by cycC/Cdk8; red line indicates RNA
polymerase that is detached from DNA; green line indicates RNA polymerase that is actively transcribing DNA. In order to accomplish the initial
cell division in a reasonable time, a large number of RNA polymerase is held inactive during G0.
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These transcription factors induce a number of other
molecules (Table 1). The amount of induction is calcu-
lated as the product of factors quantifying the visibility
of the gene locus and the amount of the transcription
factor (see Predictions). The amount of the transcription
factor is often added to that of other transcription fac-
tors or a constitutive factor to determine the overall
multiplicative effect. Transcription in total is limited by
the number of RNA polymerase and nucleotides; thus,
the transcription factors determine what fraction of
transcription is devoted to a particular gene. Similarly,
translation in total is limited by the number of ribo-
somes and amino acids; thus, the amount of each
mRNA determines what fraction of translation is
devoted to a particular protein.
The accumulating cyc/Cdk eventually bind all p27,
allowing the accumulation of active (unbound) cyc/Cdk
(especially cycE/Cdk2), which cause an abrupt release of
the p27-bound cyc/Cdk. Free p27 are ubiquitinated by
KPC.
A timing problem occurs because cycE, its activator
Cdc25A, and its ubiquitinator Fbw7 are all induced at the
same time in G1 by the E2F transcription factors. The
model explains how the activities of these molecules
occur at different times as follows. Constitutive APC
(Cdh1) ubiquitinates both Cdc25A (which can activate
cyc/Cdk) and SCF (which can inactivate cycE/Cdk2 with
subunit Fbw7), but SCF is ubiquitinated more effectively
than Cdc25A. Thus, as the concentration of active APC
(Cdh1) decreases during G1 with the accumulation of
cycD/Cdk4or6, first Cdc25A appears and abruptly acti-
vates the newly p27-unbound cycE/Cdk2 (causing the
cycE/Cdk2-Cdc25A cascade), then SCF appears and
binds Fbw7 and ubiquitinates cycE. (The cascade starts
because of a low level of spontaneous dephosphorylation
of cycE/Cdk2.) Ubiquitination of cycE subsequently frees
Cdk2 for binding to cycA during S phase.
Iwamoto et al. [4] postulate an intermediate factor “X”
for the delay between the accumulation of cycE and
cycA during G1. The example model does include NF-Y
as an additional transcription factor for cycA. The delay,
however, is caused primarily by APC(Cdh1) ubiquitina-
tion of cycA (APC(Cdh1) does not interact with cycE).
APC(Cdh1) is not included in the Iwamoto et al. model.
Another timing problem occurs because SCF must
bind, in turn, subunit Fbw7, then subunit Skp2, then
subunit Btrc (Figure 6). The three subunits are present
at the same time beginning in G1. This timing problem
is solved in the model by SCF having greater affinity for
Fbw7 than Skp2, and having greater affinity for Skp2
than Btrc. All of these SCF complexes autoubiquitinate
when no substrate is present [36]. So, SCF preferentially
binds Fbw7, which autoubiquitinates when cycE is gone;
then SCF preferentially binds Skp2, which autoubiquiti-
nates when p27, cycE, E2F, and RC (replication com-
plex) are gone; then SCF binds Btrc. In the model, only
the subunits autoubiquitinate, leaving SCF to immedi-
ately bind another subunit [37].
The cycE/Cdk2-Cdc25A cascade marks entry into S
phase, which lasts approximately 8 hours. E2F induces
proteins such as ORC1 and Cdc6 that contribute to
DNA replication complexes (RC). RC mark 15,000 bind-
ing locations on DNA and, when activated by cycE/
Cdk2 or cycA/Cdk2, allow binding of DNA polymerase
to these locations and subsequent DNA replication [33].
Figure 7 indicates how RC are first bound to DNA, then
how RC are licensed (activated by Cdk2), then how RC
are traversed (bound) by DNA polymerase. The model
includes continual RC binding and unbinding from
DNA, as well as continual decay of the RC. DNA poly-
merase only attach and traverse licensed RC. Approxi-
mately 6000 DNA polymerase are present during S
phase. After DNA polymerase bind the RC, the RC
become delicensed. Delicensed RC are released from the
DNA and ubiquitinated by SCF(Skp2) [38,39].
Growth continues throughout S phase. Therefore, the
initiation of G2 is inexact. The initial G2 phase lasts
approximately 12 hours; subsequent G2 phases last
approximately 7 hours. Although the amount of DNA is
double during G2, the transcription rate does not
increase–transcription rate is dependent on the number
of RNA polymerase.
The termination of G2 occurs abruptly, with the cycB/
Cdk1-Cdc25C cascade. Figure 8 shows that inactive
cycB/Cdk1 begins accumulating at the beginning during
S phase, but at a much faster rate than does cycA/Cdk1.
The numbers of cycB/Cdk1 are much greater because of
greater transcription and because most cycA binds
nuclear Cdk2. In the model, Wee1 suppresses cycB/
Cdk1 more strongly than it suppresses cycA/Cdk1.
Hence, the activation cascade between cycB/Cdk1 and
Cdc25C is delayed when compared with the cycA/Cdk1-
Cdc25B cascade. As with cycA/Cdk1, cycB/Cdk1 is
translocated to the nucleus after activation by Plk1.
In the model, there is included an intermediary step of
a cycA/Cdk1-Cdc25B cascade, and this process could
add more complication than necessary. Some evidence
supporting this complication is suggested by [40-44].
This intermediary step does allow cycB/Cdk1 and
Cdc25C to remain completely inactive during most of
G2. Also, it offers an explanation why cycA binds Cdk1
and apparently participates in G2/M. And it offers an
explanation why Cdc25B is apparently required for via-
bility while Cdc25C apparently is not. (There is some
disagreement in the literature about the necessity of
Cdc25B and Cdc25C: Lincoln et al. [45] report that
mice lacking Cdc25B are viable; Donzelli and Draetta
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out mice are viable, but Cdc25B knockouts are not,
while Ferguson et al. [47] report that mice lacking both
Cdc25B and Cdc25C are viable. However, Lammer et al.
[41] report that Cdc25B is required for the human cell
cycle.) In the model, Cdc25B can substitute for Cdc25C
in the cycB/Cdk1-Cdc25C cascade, albeit less efficiently
than Cdc25C, but Cdc25C cannot substitute in the
cycA/Cdk1-Cdc25B cascade because it is very inactive.
Therefore, Cdc25B is essential in the model, but
Cdc25C is dispensable. As mentioned in Calibration of
the Model (Additional file 2), however, calibration might
be improved in these areas.
M phase lasts approximately 4 hours and follows the
cycB/Cdk1-Cdc25C cascade. M phase is stylized in the
example model. There is no explicit modeling of the sub-
phases (prophase, metaphase, etc.) and the mechanics of
division are implied by the lifecycles of a few molecules.
One consequence of the activation of cycB/Cdk1at
G2/M is the phosphorylation of Emi1. Phosphorylation
of Emi1 causes it to release Cdc20 and Cdh1. In the
model, APC binding with Cdc20 is favored over its
binding with Cdh1. APC(Cdc20) is activated (phos-
phorylated) in the nucleus by cycA/Cdk2, cycA/Cdk1,
and cycB/Cdk1. APC(Cdc20) then ubiquitinates Securin.
Securin accumulation begins early in G1, culminating
in its ubiquitination during and after G2/M. One role of
Securin is to inhibit Cdc14 (Figure 9); once Securin is
ubiquitinated, Cdc14 can be activated by Plk1. Another
role of Securin is keep chromotids connected. With the
Figure 6 Numbers of SCF bound to Fbw7, Skp2, and Btrc subunits over two cell divisions. All molecules are present at the same time.
First, SCF preferentially binds Fbw7 and ubiquitinates Fbw7 substrates, at which point Fbw7 autoubiquitinates. Then SCF preferentially binds
Skp2 and ubiquitinates Skp2 substrates (in particular, replication complexes RC) at which point Skp2 autoubiquitinates. Finally, SCF binds Btrc,
concluding the sequence.
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rate and the cell divides.
Figure 9 shows that quantities of the phosphatase Cdc14
exist in the nucleus throughout the cell cycle, although
usually in an inactive or inhibited state. When active Plk1
moves into the nucleus, and when Securin has been ubi-
quitinated by APC(Cdc20), Plk1 can phosphorylate and
activate Cdc14 (after [48]). In the model, Cdc14 represents
the entire mitotic-exit-network (MEN) pathway. Cdc14
causes the cell to exit M phase by deactivating Cdc20,
Cdc25A, Cdc25B, Cdc25C, and reactivating Wee1 (when
it is again translated), Cdh1, and, in the model, cycC/Cdk8
(although no evidence could be found for this mechanism
for reactivating cycC/Cdk8). Of immediate importance at
the end of M phase is the unbinding of APC and Cdc20
by Cdc14. Unbinding of APC(Cdc20) allows the binding
of APC and Cdh1, which causes the cell to enter either G0
or G1 (depending on the presence of mitogen), thus com-
pleting a cell cycle.
Discussion
Predictions
Predictions are here defined as necessary model features
or model results that are not well known in the field of
Cell Biology, that are not readily accepted, or that con-
tradict current interpretations. More explanation of the
evidence for predictions can be found in Additional files
3 and 4.
Figure 7 Numbers of replication complex (RC) over two cell divisions. RC (consisting of ORC1, Cdc6, etc.) is induced by E2F, accumulates in
the nucleus, and binds DNA at 15,000 replication origins. RC is licensed by cyc/Cdk, primarily cycD/Cdk4or6 and cycE/Cdk2, after which RC is
bound and traversed by DNA polymerase during DNA replication. Once traversed, the RC is released from the DNA and ubiquitinated, primarily
by SCF(Skp2). The figure also shows a modeling construct, RC-count, which is used to set and maintain the 15,000-replication-orgin limit.
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￿ When redundant pathways can activate a time-critical
p r o c e s s ,o n ep r e f e r r e dp a t h w a ym u s ti n a c t i v a t et h e
other redundant pathways. This prediction was discov-
ered studying the inactivation of Wee1 (by SCF(Btrc) or
by Cdc25A). The explanation is that with redundant
pathways, only one pathway must operate to assure cor-
rect timing; if both operate, the end reaction will pro-
ceed too quickly (unless both reactions are happening at
a slower rate, say because of reduced concentration;
however, these reactions would not be redundant). This
finding has possible implications for understanding
cycE-knockout and Cdc25C-knockout experiments (e.g.,
as discussed in [49,50]), because these knockouts could
involve redundant pathways.
￿ Explicit growth monitoring is unnecessary during the
mammalian cell cycle. Abundances of major reactants
that advance the cell cycle are explicitly tied to overall
cell growth, and the progression of the cell-cycle phases
is, for the most part, dependent on cell growth. The abil-
ity to alter the timing of the cell cycle by artificially intro-
duced regulatory proteins (as discussed by [49]) supports
this finding. Novak and Tyson [8] propose that a “timer”
process–similar to the prediction stated here–takes over
in the cell cycle after a certain size is reached. Csikász-
Nagy et al. [18] propose an “oscillator” process–similar to
the prediction here–for quickly growing cells. Qu et al.
[15] and Yang et al. [16] offer alternative viewpoints
based on concentrations constrained by membrane
transport.
Figure 8 Numbers of cycB/Cdk1 over two cell divisions. cycB and Cdk1 are induced and enhanced by E2F, B-Myb, and NF-Y. Cdk1 also has
constitutive expression. cycB/Cdk1 accumulates during S phase but is phosphorylated and inactivated by Wee1. Loss of Wee1 and the presence
of active Cdc25B (activated by cycA/Cdk1) begin the dephosphorylation and activation of cycB/Cdk1 and thus trigger the cascade between
cycB/Cdk1 and constitutive Cdc25C. Active cycB/Cdk1 further activates Plk1, which promotes the translocation of cycB/Cdk1 to the nucleus,
completing the G2/M transition.
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cing or the number of RNA polymerase) is unnecessary
during the cell cycle. Here, pre-translation mRNA regu-
lation is defined as the process of limiting abundances
of specific proteins by storing, destroying, or specifically
selecting for translation their mRNA, e.g., by RNA inter-
ference or by storage of mRNA.
￿ Transcription and translation (i.e., growth) continues
during S phase at unimpeded rates. If transcription and
translation ceased during S phase, the duration of the
modeled cell cycle would be extended by several hours,
which would not match observations.
￿ Because a significant number of DNA polymerase is
needed in short order during the initial cell cycle from
G0, either a supply of DNA polymerase must be kept
inactive during G0 or intense transcription and
translation activity must occur and be controlled at a
saturation level (as modeled).
￿ Cdc25A and Cdc25B cooperate to instigate the cycB/
Cdk1-Cdc25C cascade and the G2/M transition. Evi-
dence from the model is as follows. Negating the depho-
sphorylation of cycB/Cdk1 by Cdc25A lengthens G2
significantly. Similarly, reducing the ubiquitination of
Cdc25A by SCF(Btrc) shortens G2 significantly. (If SCF
(Btrc) is completely removed, however, the timing of
G2/M is unaffected in the model and as noted experi-
mentally by [51].) And negating the dephosphorylation
of cycA/Cdk1 by Cdc25B also appreciably lengthens G2.
￿ During G0, a readily available supply of inactive
RNA polymerase must be present in cells that are cap-
able of dividing. In the model the supply is in the form
of RNA polymerases held inactive by cycC/Cdk8.
Figure 9 Numbers of Cdc14 (representing the MEN pathway) over two cell divisions. Cdc14 is a phosphatase that functions to activate
p27, Wee1, and Cdh1 and deactivate the Cdc25 phosphatases, thus resetting the cell cycle after cell division. Cdc14 is constitutively expressed
and rapidly translocated to the nucleus. Most of cell cycle, Cdc14 is inhibited by Securin. Cdc14 is activated when phosphorylated by nuclear
Plk1after Securin is degraded.
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for the cell to produce enough RNA polymerases to
initiate the first cell division after G0.
￿ SCF progressively complexes with Fbw7, Skp2, and
Btrc through the cell cycle because of differences in affi-
nity of these subunits with SCF and because of autoubi-
quitination in the absence of substrates.
￿ Part of the timing of G1/S is determined by a prefer-
ence for APC(Cdh1) to ubiquitinate SCF over Cdc25A,
allowing the cycE/Cdk2-Cdc25A cascade to proceed
before SCF/Fbw7 ubiquitinates cycE.
￿ Transcription factors act multiplicatively.
￿ All cell-cycle reactions are interconnected with each
other and with the basic cellular machinery.
Molecular-level predictions
￿ p27 is important for maintaining G0 and for timing
the duration of G1 in the first cell cycle after exiting
G0. p27 does not have a significant role in timing G1 in
continuous cell cycling. The duration of G1 in subse-
quent cell cycles is timed by APC(Cdh1).
￿ p27 does not inhibit cycD/Cdk4 or cycD/Cdk6 activ-
ity, although p27 does bind these complexes (as experi-
mentally indicated by [52] and also suggested by [8];
Iwamoto et al. [4] assert that p27 binding activates
cycD/Cdk4or6). The reason for this ineffectiveness is
that growth induced by cycD/Cdk4or6 must proceed
while p27 is still available, especially in consecutive cell
cycles. p27 does block cycE/Cdk2 and is important in
timing S phase in the first cycle after G0.
￿ cycD/Cdk4or6 does not activate DNA replication
complexes. These cycD complexes are active throughout
G1, S, and G2; if they activate RC, DNA replication
would occur throughout much of the cell cycle.
￿ Wee1 spontaneously reactivates, either because of
spontaneous dephosphorylation or because of continu-
ous dephosphorylation by action of a phosphatase, per-
haps PP2A [53]. There would otherwise be no need for
SCF(Btrc) to ubiquitinate Wee1.
￿ Plk1 is the primary inactivator of Wee1 (via phos-
phorylation). Plk1 has more consistent active concentra-
tions than other candidates (cycA/Cdk1 and cycB/Cdk1)
over the first cycle after G0 and subsequent cycles.
￿ The reason why cycA binds Cdk1 is so that cycA/
Cdk1 can react with either Cdc25A or Cdc25B and
“prime the pump” for the cycB/Cdk1-Cdc25C cascade.
￿ Not all RNA polymerase are removed from con-
densed DNA during mitosis; the number attached is
approximately the number active during G0.
Parameter estimation
The parameters for the example model were determined
by generate and test, albeit highly constrained by cali-
bration (Additional file 2). Changes to some input
parameters in the example cell-cycle model can cur-
rently cause large effects on the solution, including
numerical instabilities. Evolution likely determined the
set of initial values and rate constants that minimize
sensitivity to change, and the model should be likewise
calibrated. The author knows of no work in automati-
cally determining the most robust set of parameters for
a coupled-ODE model with multiple time-based con-
straints. Such a method would benefit not just cell-cycle
modeling, but modeling complex biologic systems in
general. This issue was also raised by [18].
Possible improvements to the example model
Major areas of possible improvement to the example
model include addressing many of the assumptions and
simplifications (Additional file 1), improving calibration
(Additional file 2), adding cell-cycle checkpoints, incor-
porating membrane receptors and growth-factor and
adhesion-factor pathways, and adding chromatin manip-
ulations during DNA replication [54] and M phase. Some
preliminary work has indicated that these improvements
are not inconsistent with the model or the framework.
Conclusions
A framework for modeling complex cell-biologic path-
ways is described here. The framework includes a
description of the entire lifecycles of the modeled mole-
cules, combined with a description of the basic cellular
machinery. These constructs foster completeness and
rigor–qualities that will be necessary as biological models
grow in scope and detail. The framework is applied to a
model of the growth and division of mammalian cells.
The example model has been exercised and found to
generate non-trivial descriptions of the cell cycle, some
of which could be worthy of experimental confirmation.
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